Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,214,197
-
Share change
-
-104,975
-
Total reported value
-
$12,081,502
-
Price per share
-
$9.95
-
Number of holders
-
51
-
Value change
-
-$993,068
-
Number of buys
-
20
-
Number of sells
-
20
Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q3 2025
As of 30 Sep 2025,
Greenwich LifeSciences, Inc. - COM (GLSI) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,214,197 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, MARSHALL WACE, LLP, DEUTSCHE BANK AG\, CITADEL ADVISORS LLC, and STRS OHIO.
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.